Article info
PDFClinical science
Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision
- Correspondence to Dr Ronald E P Frenkel, East Florida Eye Institute, 509 SE Riverside Dr #302, Stuart, FL 34994, USA; efleye{at}aol.com
Citation
Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision
Publication history
- Received July 30, 2015
- Revised September 15, 2015
- Accepted October 16, 2015
- First published November 5, 2015.
Online issue publication
July 21, 2016
Article Versions
- Previous version (21 July 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/